Professor, Pathology, UC, Davis School of Medicine
Pathology
Dr. Ishwarlal K. Jialal, MD
|
|
Give Review
Dr. Ishwarlal K. Jialal practices Pathology. Ishwarlal Jialal is also a published physician. He has 97 publication published. The most recent publication is: alpha-Tocopherol enrichment of monocytes decreases agonist-induced adhesion to human endothelial cells. He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Toll-like receptors 2 and 4 mediate hyperglycemia induced macrovascular aortic endothelial cell inflammation and perturbation of the endothelial glycocalyx.
- Endosomal Toll-Like Receptor Status in Patients with Metabolic Syndrome.
- Plasma fetuin-A does not correlate with monocyte TLR4 in humans.
- Cellular Signaling in Metabolic Syndrome.
- PCSK9 Inhibitors: The Next Frontier in Low-Density Lipoprotein Lowering.
- Circulating pathogen associated molecular pattern - Binding proteins and High Mobility Group Box protein 1 in nascent metabolic syndrome: Implications for cellular Tol...
- Endotoxemia of Metabolic Syndrome: A Pivotal Mediator of Meta-Inflammation.
- Increased Adipose Tissue Insulin Resistance in Metabolic Syndrome: Relationship to Circulating Adipokines.
- Relationship Between Retinol-Binding Protein-4/Adiponectin and Leptin/Adiponectin Ratios with Insulin Resistance and Inflammation.
- Comment on: Lopes-Virella MF, et al. Baseline Markers of Inflammation Are Associated With Progression to Macroalbuminuria in Type 1 Diabetic Subjects Diabetes Care 201...
- No Benefit of Saxagliptin on Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Potential Explanations.
- Toll-like Receptor Status in Obesity and Metabolic Syndrome: A Translational Perspective.
- Human C-reactive protein induces endothelial dysfunction in biobreeding diabetic rats.
- A novel peptide inhibitor attenuates C-reactive protein's pro-inflammatory effects in-vivo.
- Increased Expression of Fc-γ Receptors on Monocytes in Patients With Nascent Metabolic Syndrome.
- Small Interfering-RNA to Protein Kinase C-Delta Reduces the Proinflammatory Effects of Human C-Reactive Protein in Biobreeding Diabetic Rats.
- Inflammation, atherosclerosis, and psoriasis.
- Modulation of endothelial progenitor cell number and function with n-3 polyunsaturated fatty acids.
- Strategies to Lower Low-Density Lipoprotein Cholesterol in Metabolic Syndrome: Averting the Diabetes Risk.
- Synthesis and Characterization of a Novel Inhibitor of C-Reactive Protein-Mediated Proinflammatory Effects.
- Effects of Aloe vera Supplementation in Subjects with PreDiabetes/Metabolic Syndrome.
- DPP-4 inhibitors and atherosclerosis: The promise.
- Increased Neutrophil Count in Nascent Metabolic Syndrome.
- Increased Chemerin and Decreased Omentin-1 in Both Adipose Tissue and Plasma in Nascent Metabolic Syndrome.
- Hyperglycemia induced Toll like receptor 4 Expression and Activity in Mouse Mesangial cells: Relevance to Diabetic Nephropathy.
- Increased Cellular and Circulating Biomarkers of Oxidative Stress in Nascent Metabolic Syndrome.
- Antisense to protein kinase C-alpha and p47phox attenuates the pro-inflammatory effects of human C-reactive protein in macrophages of biobreeding diabetic rats.
- Resveratrol up-regulates SIRT1 and inhibits cellular oxidative stress in the diabetic milieu: mechanistic insights.
- Managing the dysLipidemia of metabolic syndrome: beyond statin therapy.
- Human C-reactive protein accentuates macrophage activity in biobreeding diabetic rats.
- Hyperglycemia induces Toll-like receptor-2 and -4 expression and activity in human microvascular retinal endothelial cells: implications for diabetic retinopathy.
- Amelioration in wound healing in diabetic toll-like receptor-4 knockout mice.
- Adipose tissue dysfunction in nascent metabolic syndrome.
- Effect of statin therapy on remnant lipoprotein cholesterol levels in patients with combined Hyperlipidemia.
- Divergence between LDL oxidative susceptibility and urinary F(2)-isoprostanes as measures of oxidative stress in type 2 Diabetes.
- Heterozygosity for the mouse Apex gene results in phenoTypes associated with oxidative stress.
- Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay.
- Failure to demonstrate a major anti-inflammatory effect with alpha tocopherol supplementation (400 IU/day) in normal subjects.
- Alpha-tocopherol and atherosclerosis.
- Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels.
- Alpha-tocopherol decreases CD36 expression in human monocyte-derived macrophages.
- Low-density lipoprotein (LDL)-induced monocyte-endothelial cell adhesion, soluble cell adhesion molecules, and autoantibodies to oxidized-LDL in chronic renal failure ...
- Is there a vitamin E paradox?
- The effect of alpha-tocopherol on monocyte proatherogenic activity.
- Association between C-reactive protein, anti-Chlamydia pneumoniae antibodies, and vascular function in healthy adults.
- Antioxidants and vitamins to reduce cardiovascular disease.
- Ratio of remnant-like particle cholesterol to serum total triglycerides is a reliable screening test for Type III dyslipidaemia.
- Standardization of lipoprotein reporting.
- Studies of LDL oxidation following alpha-, gamma-, or delta-tocotrienyl acetate supplementation of hypercholesterolemic humans.
- Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and Type 2 diabetic patients.
- How specific is cardiac troponin?
- Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in Type 2 diabetic patients with and without macrovascular co...
- Measurement of Lipid-soluble vitamins--further adjustment needed?
- Vitamin E supplementation and cardiovascular events in high-risk patients.
- Remnant-like particle-cholesterol concentrations in patients with type 2 Diabetes mellitus and end-stage renal disease.
- Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy.
- Validation of an immunoassay for measurement of plasma total homocysteine.
- Comparison of the effect of alpha-lipoic acid and alpha-tocopherol supplementation on measures of oxidative stress.
- Cyclosporin A does not increase the oxidative susceptibility of low density lipoprotein in vitro.
- Alpha-tocopherol decreases interleukin-1 beta release from activated human monocytes by inhibition of 5-lipoxygenase.
- Measurement of protein carbonyls in plasma of smokers and in oxidized LDL by an ELISA.
- alpha-Tocopherol enrichment of monocytes decreases agonist-induced adhesion to human endothelial cells.
- Comparison of 2 homogeneous high-density lipoprotein cholesterol assays.
- Evaluation of a rapid homogeneous method for direct measurement of high-density lipoprotein cholesterol.
- Evolving lipoprotein risk factors: lipoprotein(a) and oxidized low-density lipoprotein.
- Remnant-like particle cholesterol levels in patients with dysbetalipoproteinemia or coronary artery disease.
- Effects of increasing doses of alpha-tocopherol in providing protection of low-density lipoprotein from oxidation.
- Detection of oligoclonal bands in cerebrospinal fluid by immunofixation electrophoresis.
- The effects of alpha-tocopherol on critical cells in atherogenesis.
- Bimonthly update: Lipidology. Therapy and clinical trials.
- Dose-response comparison of RRR-alpha-tocopherol and all-racemic alpha-tocopherol on LDL oxidation.
- A more valid measurement of low-density lipoprotein cholesterol in diabetic patients.
- Comparison of two assays for measuring LDL cholesterol.
- Comparison of cardiac troponin I and lactate dehydrogenase isoenzymes for the late diagnosis of myocardial injury.
- Effect of alpha-tocopherol on LDL oxidation and glycation: in vitro and in vivo studies.
- Superoxide production and LDL oxidation by diabetic neutrophils.
- Effect of ascorbate supplementation on low density lipoprotein oxidation in smokers.
- Troponin I in hypothyroidism.
- Oxidatively modified LDL and atherosclerosis: an evolving plausible scenario.
- A practical approach to the laboratory diagnosis of dysLipidemia.
- The effects of alpha tocopherol supplementation on monocyte function. Decreased Lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium.
- Plasma oxidizability in Mexican-Americans and non-Hispanic whites.
- The role of oxidized low density lipoprotein in atherogenesis.
- RRR-alpha-tocopheryl acetate supplementation at pharmacologic doses decreases low-density-lipoprotein oxidative susceptibility but not protein glycation in patients wi...
- Low-density lipoprotein oxidation, antioxidants, and atherosclerosis: a clinical biochemistry perspective.
- Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM.
- Greater frequency of increased cardiac troponin T than increased cardiac troponin I in patients with chronic renal failure.
- Nonspecific elevation of troponin T levels in patients with chronic renal failure.
- Oxidized LDL and antioxidants.
- Identification of two new LDL-receptor mutations causing homozygous familial hypercholesterolemia in a South African of Indian origin.
- LDL modification by activated polymorphonuclear leukocytes: a cellular model of mild oxidative stress.
- Effect of combined supplementation with alpha-tocopherol, ascorbate, and beta carotene on low-density lipoprotein oxidation.
- A critical assessment of the effects of aminoguanidine and ascorbate on the oxidative modification of LDL: evidence for interference with some assays of lipoprotein ox...
- Effects of antioxidants and fatty acids on low-density-lipoprotein oxidation.
- Susceptibility of plasma to ferrous iron/hydrogen peroxide-mediated oxidation: demonstration of a possible Fenton reaction.
- Cadmium and atherosclerosis: Heavy metal or singing the blues?
Conditions Treated
- Diabetes Type 2
- HyperLipidemia
- Lipid Disorders
- Osteopenia
- View All
Doctors Specialties
- Chemical Pathology
- Pathology
Accepted Insurances
Hospital
-
University of California, Davis Medical Center
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1568447571 |
| Last Name Of The Provider | JIALAL |
| First Name Of The Provider | ISHWARLAL |
| View All |
Similar Doctors
|
|
Dr. Daniel A. Egerter, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bruce N. Burdick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nalini Madiraju, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary E. Keohane, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian M. Nagao, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chihong H. Zhou, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lars F. Berglund, MD
This Doctor is OpenDoctor Recommended.
|